(Q48309631)

10 February 2018

title

Safety Pharmacology Society: 9th Annual Meeting (English)

1 reference

10 February 2018

1 reference

Icilio Cavero

1

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 March 2010

1 reference

10 February 2018

Expert Opinion on Drug Safety

published in

1 reference

10 February 2018

volume

9

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

365-378

1 reference

10 February 2018

Can pharmacogenetics help rescue drugs withdrawn from the market?

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Chronobiology and chronotherapy of ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Cardiovascular changes during daily torpor in the laboratory mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Alternative strategies for toxicity testing of species-specific biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

The presence of pharmaceuticals in the environment due to human use--present knowledge and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

In silico tools for sharing data and knowledge on toxicity and metabolism: derek for windows, meteor, and vitic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

A framework to assess the translation of safety pharmacology data to humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Animal models of human disease in drug safety assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Histamine H3 receptors modulate antigen-induced bronchoconstriction in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Preclinical Torsades-de-Pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

Ecopharmacology: a new topic of importance in pharmacovigilance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740331003625577

10.1517/14740331003625577

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018